學門類別
最新個案
- Leadership Imperatives in an AI World
- Vodafone Idea Merger - Unpacking IS Integration Strategies
- V21 Landmarks Pvt. Ltd: Scaling Newer Heights in Real Estate Entrepreneurship
- Snapchat’s Dilemma: Growth or Financial Sustainability
- Did I Just Cross the Line and Harass a Colleague?
- Predicting the Future Impacts of AI: McLuhan’s Tetrad Framework
- Porsche Drive (A) and (B): Student Spreadsheet
- Porsche Drive (B): Vehicle Subscription Strategy
- TNT Assignment: Financial Ratio Code Cracker
- Winsol: An Opportunity For Solar Expansion
Pfizer and the Challenges of the Pharmaceutical Industry (B)
內容大綱
Case B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers between 2007 and 2018.
學習目標
After working through the assignment questions for Case B, students will be able to do the following:<ul><li>Analyze how pharmaceutical companies strategically respond to changes in the industry.</li><li>Delineate a variety of approaches to reacting to opportunities and threats in the industry (drawing on the analyses in Case A).</li><li>Discuss theory—global integration versus local responsiveness—and apply it to international companies’ strategy-making.</li><li>Identify, analyze, and evaluate relevant data and information.</li></ul>